Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'Court Delivers Another Blow to Tirzepatide Compounders'
Tweet Send to a Friend
Citi analyst Daniel Grosslight reiterated a Sell rating and $27.00 price target on Hims and Hers (NYSE: HIMS).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
